₹417.85
▲ +3.23 +0.78%
As of 26 Oct 2026 · delayed
NSE Listed
SMS Pharmaceuticals Ltd. (SMSPHARMA)
Volume: 2,25,037Avg Vol 1W: 3,09,053Avg Vol 1M: 3,81,479.652W Range:₹270.1₹494.45
Key Ratios
Checked 6h agoMarket Cap₹3,913 Cr
Current Price₹417.85
Previous Close₹414.62
High / Low (52w)₹494.45 / ₹270.1
Volume2,25,037
Avg Vol (1W)3,09,053
Avg Vol (1M)3,81,479.6
Stock P/E38.23
Book Value₹83.91
Dividend Yield10%
ROE12.98%
ROA6.57%
Revenue (TTM)₹895 Cr
Revenue Growth10.4%
Profit Margin11.41%
Total Debt₹139 Cr
Shares Outstanding9 Cr
Face Value₹1
EPS (TTM)₹10.93
P/B4.98
Debt / Equity0.47
50 DMA₹416.5
200 DMA₹388.05
Day change+0.78%
Price Chart
₹417.85▲ 39.42% · 1Y
2025-10-272026-10-26
20-day avg volume: 3.8L shares
Pros
- Pays a dividend yield of 10.0%.
- Company is almost debt-free.
- Revenue grew 12% YoY.
- Net profit is growing year over year.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹197 Cr | ₹173 Cr | ₹248 Cr | ₹196 Cr | ₹242 Cr | ₹210 Cr | ₹238 Cr | ₹207 Cr |
| EBITDA | ₹24 Cr | ₹27 Cr | ₹34 Cr | ₹30 Cr | ₹40 Cr | ₹37 Cr | ₹32 Cr | ₹33 Cr |
| Net Profit | ₹14 Cr | ₹18 Cr | ₹20 Cr | ₹20 Cr | ₹25 Cr | ₹23 Cr | ₹33 Cr | ₹21 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹789 Cr | ₹248 Cr | ₹196 Cr | ₹242 Cr | ₹210 Cr | ₹238 Cr | ₹895 Cr | ₹207 Cr |
| EBITDA | ₹111 Cr | ₹34 Cr | ₹30 Cr | ₹40 Cr | ₹38 Cr | ₹32 Cr | ₹140 Cr | ₹34 Cr |
| Net Profit | ₹69 Cr | ₹21 Cr | ₹18 Cr | ₹25 Cr | ₹23 Cr | ₹21 Cr | ₹102 Cr | ₹21 Cr |
| EPS | 8.16 | — | — | — | — | — | 9.58 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹559 Cr | ₹608 Cr | ₹812 Cr | ₹860 Cr | ₹880 Cr | ₹1,034 Cr | ₹1,153 Cr | ₹1,362 Cr |
| Total Liabilities | ₹237 Cr | ₹260 Cr | ₹402 Cr | ₹389 Cr | ₹419 Cr | ₹498 Cr | ₹513 Cr | ₹577 Cr |
| Equity | ₹322 Cr | ₹348 Cr | ₹411 Cr | ₹470 Cr | ₹461 Cr | ₹536 Cr | ₹640 Cr | ₹786 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹63 Cr | ₹52 Cr | ₹106 Cr | ₹60 Cr | ₹27 Cr | ₹66 Cr | ₹102 Cr | ₹83 Cr |
| Investing | ₹-35 Cr | ₹-43 Cr | ₹-152 Cr | ₹-27 Cr | ₹-30 Cr | ₹-52 Cr | ₹-123 Cr | ₹-131 Cr |
| Financing | ₹-13 Cr | ₹-2 Cr | ₹92 Cr | ₹-12 Cr | ₹-32 Cr | ₹31 Cr | ₹47 Cr | ₹76 Cr |
| Free Cash Flow | ₹63 Cr | ₹52 Cr | ₹107 Cr | ₹60 Cr | ₹27 Cr | ₹66 Cr | ₹102 Cr | ₹83 Cr |
Shareholding
Promoter 68.07% Institutions 1.37% Public 30.56%
Efficiency & Working Capital
ROCE12.1%
Interest Coverage6
Dividend Payout—
Debtor Days81 d
Inventory Days132 d
Payable Days45 d
Cash Conversion Cycle168 d
Working Capital Days213 d
Shareholding Details
As of 2026-09-30
Promoter68.1%
FII1.2%
DII0.2%
Institutions1.4%
Public30.6%
Promoter Pledge18%
No. of Shareholders34,904
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 64.3% | 64.7% | 64.7% | 64.7% | 64.7% | 66.3% | 66.3% | 68.1% | 68.1% | 68.1% | 68.1% | 68.1% |
| FIIs | 0.6% | 0.2% | 0.2% | 0.5% | 0.3% | 0.1% | 0% | 0.3% | 0% | 0.3% | 0.6% | 1.2% |
| DIIs | 0% | 2% | 2.1% | 2.5% | 2.5% | 2.4% | 3% | 2.9% | 3.2% | 3% | 2.8% | 0.2% |
| Public | 35.1% | 33.2% | 33% | 32.3% | 32.5% | 31.2% | 30.7% | 28.8% | 28.7% | 28.6% | 28.5% | 30.6% |
| Promoter Pledge | 19.5% | 19.4% | 19.4% | 19.4% | 19.4% | 37.6% | 37.6% | 34.7% | 18% | 18% | 18% | 18% |
| No. of Shareholders | 25,341 | 30,140 | 31,780 | 33,136 | 34,973 | 35,332 | 33,652 | 34,157 | 34,378 | 32,397 | 31,489 | 34,904 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ramesh Babu Potluri | Shareholding of Promoter and Promoter Group | 19.4% | 1.82 Cr |
| Vamsi Krishna Potluri | Shareholding of Promoter and Promoter Group | 16.9% | 1.58 Cr |
| Hima Bindu Potluri | Shareholding of Promoter and Promoter Group | 16% | 1.50 Cr |
| Potluri Infra Projects Llp | Shareholding of Promoter and Promoter Group | 9.5% | 88,46,420 |
| Trilok Potluri | Shareholding of Promoter and Promoter Group | 5% | 46,88,000 |
| Aniruddh Mundra | Public Shareholding | 1.8% | 17,22,385 |
| Venkata Subbaraju Penmatsa Huf | Public Shareholding | 1.6% | 15,00,000 |
| Alpana Mundra | Public Shareholding | 1.5% | 14,03,638 |
| Venkata Praveen Talluri | Public Shareholding | 1.4% | 13,20,170 |
| Sudeepthi Gopineedi | Public Shareholding | 1.4% | 13,20,170 |
| Potluri Laboratories Private Limited | Shareholding of Promoter and Promoter Group | 1.2% | 11,20,320 |
| Tvt Infracon Llp | Shareholding of Promoter and Promoter Group | 0.1% | 1,00,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Hima Bindu Potluri | 30,00,000 | 20% | 2026-09-30 |
| Potluri Laboratories Private Limited | 11,20,320 | 100% | 2026-09-30 |
| Potluri Infra Projects Llp | 73,46,420 | 83% | 2026-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| P Ramesh Babu | Chairman / Executive Director / Managing Director | 2025 |
| Sarvepalli Srinivas | Independent Non Exe. Director | 2025 |
| Shravan Kudaravalli | Independent Non Exe. Director | 2025 |
| G Suresh Kumar | Independent Non Exe. Director | 2025 |
| Shanti Sree Bolleni | Independent Non Exe. Director | 2025 |
| Trilok Potluri | Non-Exec & Non-Independent Dir | 2025 |
| Sunkara Venkata Satya Shiva Prasad | Non-Exec & Non-Independent Dir | 2025 |
| Vamsi Krishna potluri | Executive Director | 2025 |
| Thirumalesh Tumma | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing and Sale of Active Ph | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Exports | ₹326 Cr | 62.4% |
| Deemed Exports | ₹16 Cr | 3% |
| Domestic | ₹178 Cr | 34.1% |
| Export Incentives | ₹2 Cr | 0.4% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 12 | 9 | 9 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-09-22 | Dividend | — |
| dividend | 2026-09-22 | ₹0.4 (40%) | Final |
| forthcoming | 2026-09-16 | Dividend | — |
| forthcoming | 2026-09-16 | Dividend (0.4/- per share) | Final |
| dividend | 2026-09-16 | ₹0.4 (40%) | Final |
| forthcoming | 2026-08-01 | Board Meetings | — |
| forthcoming | 2026-07-31 | Board Meetings | — |
| dividend | 2025-09-22 | ₹0.4 (40%) | Final |
| forthcoming | — | Book Closure | AGM |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 59 | 0 | 11 | 17 | 88 |
| 2025 | 0 | 19 | 0 | 11 | 17 | 48 |
| 2025 | 0 | 40 | 0 | 0 | 0 | 40 |
Insider / Designated-Person Trades
13 recent disclosure(s)
NVV SatyanarayanaDisposal · 2,050
NVV SatyanarayanaDisposal · 1,000
N. Srilakshmi PadminiAcquisition · 3,000
P. Deepthi SriDisposal · 5,000
P. ManideepDisposal · 1,000
P. ManideepDisposal · 1,500
Substantial Acquisitions (SAST)
3 disclosure(s)
Release Of Pledge03/11/2025 · —
Pledge Released03/11/2025 · —
Pledge Released03/11/2025 · —
Company Information
Incorporated1987
ChairmanP Ramesh Babu
AuditorSuryanarayana & Suresh
Investor Email[email protected]; [email protected];
📍 8th Floor Trendset Jayabheri, Connect Kondapur Serilingampal, Hyderabad, Telangana, 500084
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search